# Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

> **NCT01106430** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 267 (actual)

## Conditions studied

- Attention-Deficit/Hyperactivity Disorder

## Interventions

- **DRUG:** Lisdexamfetamine Dimesylate
- **DRUG:** Atomoxetine Hydrochloride

## Key facts

- **NCT ID:** NCT01106430
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-28
- **Primary completion:** 2012-07-19
- **Final completion:** 2012-07-19
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01106430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01106430, "Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01106430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*